跳至主要内容
临床试验/NCT01920815
NCT01920815已完成不适用

Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study

Oregon Health and Science University6 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
500
试验地点
6
主要终点
Change in aortic area measured by MRI

研究概览

简要总结

In order to determine the effectiveness of medical therapy options to prevent enlargement of the aorta in patients with a bicuspid aortic valve, a randomized study will be planned. This feasibility study will gather accurate data on number needed to screen, changes in medication use over time, and variance of the intended study endpoint.

详细描述

The study will consider all patients with a bicuspid aortic valve and 1) determine the number of patients needed to be screened for a clinical trial, based on patient eligibility percentages applying specific inclusion and exclusion criteria, 2) for those meeting these criteria, follow changes in and compliance with medical therapy over two years, and 3) in a limited subset of eligible patients, perform MRI at baseline and after 2 years to measure the change in aortic area over time.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Bicuspid aortic valve
  • Aortic measurement of 35 - 49 mm on prior imaging study

排除标准

  • Prior aortic valve or thoracic aortic surgery
  • Prior aortic dissection
  • Other condition associated with enlarged aorta including Coarctation, Marfans, Turner syndrome, Loeys-Dietz, etc.
  • Severe aortic stenosis or regurgitation
  • Contraindication to MRI such as claustrophobia or implanted pacer/defibrillator
  • Anticipated pregnancy, surgery, or move outside the area within 2 years

结局指标

主要结局

Change in aortic area measured by MRI

时间窗: 24 months

Patients will have a baseline and follow up MRI per a specific protocol to measure area of the ascending thoracic aorta. All measurements will be performed by a core imaging lab

次要结局

  • Clinical events involving the aorta, including change in medical therapy(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Craig Broberg

Associate Professor

Oregon Health and Science University

研究点 (6)

Loading locations...

相似试验